The U.S. drug regulator on Monday granted full approval to the Pfizer Inc  /BioNTech SE  COVID-19 vaccine, making it the first to secure such Food and Drug Administration validation as health authorities struggle to win over vaccine skeptics during a relentless pandemic. The FDA, which gave the two-dose vaccine emergency-use authorization in Continue Reading